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A B S T R A C T
Background
Exercise-based cardiac rehabilitation may benefit adults with atrial fibrillation or those who had been treated for atrial fibrillation. Atrial
fibrillation is caused by multiple micro re-entry circuits within the atrial tissue, which result in chaotic rapid activity in the atria.
Objectives
To assess the benefits and harms of exercise-based rehabilitation programmes, alone or with another intervention, compared with no-
exercise training controls in adults who currently have AF, or have been treated for AF.
Search methods
We searched the following electronic databases; CENTRAL and the Database of Abstracts of Reviews of Effectiveness (DARE) in the
Cochrane Library, MEDLINE Ovid, Embase Ovid, PsycINFO Ovid, Web of Science Core Collection Thomson Reuters, CINAHL
EBSCO, LILACS Bireme, and three clinical trial registers on 14 July 2016. We also checked the bibliographies of relevant systematic
reviews identified by the searches. We imposed no language restrictions.
Selection criteria
We included randomised controlled trials (RCT) that investigated exercise-based interventions compared with any type of no-exercise
control. We included trials that included adults aged 18 years or older with atrial fibrillation, or post-treatment for atrial fibrillation.
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Data collection and analysis
Two authors independently extracted data. We assessed the risk of bias using the domains outlined in the Cochrane Handbook for
Systematic Reviews of Interventions. We assessed clinical and statistical heterogeneity by visual inspection of the forest plots, and by using
standard Chi² and I² statistics. We performed meta-analyses using fixed-effect and random-effects models; we used standardised mean
differences where different scales were used for the same outcome. We assessed the risk of random errors with trial sequential analysis
(TSA) and used the GRADE methodology to rate the quality of evidence, reporting it in the ’Summary of findings’ table.
Main results
We included six RCTs with a total of 421 patients with various types of atrial fibrillation. All trials were conducted between 2006
and 2016, and had short follow-up (eight weeks to six months). Risks of bias ranged from high risk to low risk.The exercise-based
programmes in four trials consisted of both aerobic exercise and resistance training, in one trial consisted of Qi-gong (slow and graceful
movements), and in another trial, consisted of inspiratory muscle training.
For mortality, very low-quality evidence from six trials suggested no clear difference in deaths between the exercise and no-exercise
groups (relative risk (RR) 1.00, 95% confidence interval (CI) 0.06 to 15.78; participants = 421; I² = 0%; deaths = 2). Very low-
quality evidence from five trials suggested no clear difference between groups for serious adverse events (RR 1.01, 95% CI 0.98 to
1.05; participants = 381; I² = 0%; events = 8). Low-quality evidence from two trials suggested no clear difference in health-related
quality of life for the Short Form-36 (SF-36) physical component summary measure (mean difference (MD) 1.96, 95% CI -2.50 to
6.42; participants = 224; I² = 69%), or the SF-36 mental component summary measure (MD 1.99, 95% CI -0.48 to 4.46; participants
= 224; I² = 0%). Exercise capacity was assessed by cumulated work, or maximal power (Watt), obtained by cycle ergometer, or by
six minute walking test, or ergospirometry testing measuring VO2 peak. We found moderate-quality evidence from two studies that
exercise-based rehabilitation increased exercise capacity, measured by VO2 peak, more than no exercise (MD 3.76, 95% CI 1.37 to
6.15; participants = 208; I² = 0%); and very low-quality evidence from four studies that exercise-based rehabilitation increased exercise
capacity more than no exercise, measured by the six-minute walking test (MD 75.76, 95% CI 14.00 to 137.53; participants = 272;
I² = 85%). When we combined the different assessment tools for exercise capacity, we found very low-quality evidence from six trials
that exercise-based rehabilitation increased exercise capacity more than no exercise (standardised mean difference (SMD) 0.86, 95%
CI 0.46 to 1.26; participants = 359; I² = 65%). Overall, the quality of the evidence for the outcomes ranged from moderate to very-
low.
Authors’ conclusions
Due to few randomised patients and outcomes, we could not evaluate the real impact of exercise-based cardiac rehabilitation onmortality
or serious adverse events. The evidence showed no clinically relevant effect on health-related quality of life. Pooled data showed a
positive effect on the surrogate outcome of physical exercise capacity, but due to the low number of patients and the moderate to very
low-quality of the underpinning evidence, we could not be certain of the magnitude of the effect. Future high-quality randomised trials
are needed to assess the benefits and harms of exercise-based cardiac rehabilitation for adults with atrial fibrillation on patient-relevant
outcomes.
P L A I N L A N G U A G E S U M M A R Y
Exercise-based cardiac rehabilitation for patients with atrial fibrillation
Background
Atrial fibrillation (AF) is the most common irregular heart beat a person can experience. It affects the heart by ’taking over’ and sending
out electric pulses that makes the heartbeat irregular and inefficient. Symptoms can include irregular heartbeat, shortness of breath,
weakness, dizziness, and fainting. Exercise-based cardiac rehabilitation aims to restore health in people with atrial fibrillation or those
who have been treated for atrial fibrillation, through regular exercise.
Review question
This systematic review assessed the benefits and harms of exercise-based cardiac rehabilitation in adults with atrial fibrillation.
Study characteristics
We included six randomised trials with a total of 421 participants. The evidence is current to July 2016.
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Key results
There were two deaths and eight serious adverse events (harmful side effects) reported in the six trials, therefore, we had insufficient
data to conclude whether exercise-based cardiac rehabilitation improved outcomes that matter the most to patients, such as death and
serious adverse events (e.g. hospitalisation). Exercise-based rehabilitation was not found to have a clinically relevant impact on quality
of life for the patient group, but may increase exercise capacity.
Quality of the evidence
The quality of the evidence ranged frommoderate to very low for all outcomes. It was possible for people in the trials to know to which
intervention group they were randomised, the reporting of the results was not complete in many trials, and for some outcomes, the
results varied across trials. These considerations limit our confidence in the overall results of the review.
Conclusions
Further randomised clinical trials that are conducted with low risks of bias and low risks of the play of chance, in a broader population
of patients with AF, are needed to assess the impact of exercise-based interventions.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise compared to No exercise for adults with atrial fibrillation
Patient or population: adults with atrial f ibrillat ion
Setting: in hospital, in municit ipalit ies1, and home-based
Intervention: Exercise
Comparison: No exercise
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with No exercise Risk with Exercise
Mortality
follow-up: 8 weeks to 6
months
Study populat ion RR 1.00
(0.06 to 15.78)
421
(6 RCTs)
⊕©©©
VERY LOW 2
Trial sequent ial analy-
sis (TSA) showed that
only 0.15% of the re-
quired information size
(141,997) was reached
5 per 1000 5 per 1000
(0 to 76)
Serious adverse events
Follow-up: 8 weeks to 6
months
Study populat ion RR 1.01
(0.98 to 1.05)
381
(5 RCTs)
⊕©©©
VERY LOW 2
TSA showed that only 1.
48% of the required in-
formation size (23,723)
was reached
26 per 1000 27 per 1000
(26 to 28)
Quality of lif e
assessed with SF-36
PCS
Scale: 0 to 100
Higher = better
Follow-up: 20 weeks to
6 months
The mean quality of lif e
in the control groups
ranged f rom 47.9 to 49.
5 points
The mean quality of lif e
in the exercise groups
was 1.96 points higher
(2.5 lower to 6.42
higher)
224
(2 RCTs)
⊕⊕©©
LOW 3
TSA showed that the re-
quired information size
of 185 part icipants was
reached. This led us to
conclude that any pos-
sible intervent ion ef -
fect, if any, was less
than 7 points
Quality of lif e
assessed with SF-36
MCS
Scale: 0 to 100
The mean quality of lif e
in the control groups
was 51.9 points
The mean quality of lif e
in the exercise groups
was 1.99 points higher
(0.48 lower to 4.46
224
(2 RCTs)
⊕⊕©©
LOW 3
TSA showed that the re-
quired information size
of 57 part icipants was
reached. This led us to
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Higher = better
Follow-up: 20 weeks to
6 months
higher) conclude that any pos-
sible intervent ion ef -
fect, if any, was less
than 7 points
Exercise capacity mea-
sured by dif ferent tools
Follow-up: 8 weeks to 4
months
The standardised mean
mean dif ference for ex-
ercise capacity was 0.
86 more in the exercise
groups (0.46 higher to
1.26 higher)
359
(6 RCTs)
⊕©©©
VERY LOW 4
Exercise capacity as-
sessed with VO2 peak
in two trials, 6-m inute
walking test in three tri-
als, and by cycle er-
gometer test in one trial
Exercise capacity
assessed with VO2
peak
Higher = better
Follow-up: 4 months to
5 months.
The mean exercise ca-
pacity in the control
groups ranged f rom 20.
7 to 32.1 mL/ kg/ m in
The mean exercise ca-
pacity was 3.76 mL/ kg/
m in higher in the exer-
cise groups
(1.37 higher to 6.15
higher)
208
(2 RCTs)
⊕⊕⊕©
MODERATE 5
TSA showed the al-
pha-spending bound-
aries for benef it were
crossed, indicat ing that
suf f icient information
was obtained, and the
result was not due to
random error
Excercise capacity
assessed with 6-minute
walking test
Higher = better
Follow-up: 12 weeks to
4 months
The mean exercise ca-
pacity ranged f rom 406.
38 to 602 meters
The mean exercise ca-
pacity was 76.76 me-
ters higher in the exer-
cise group
(14 higher to 137.53
higher)
- 272
(4 RCTs)
⊕©©©
VERY LOW 3
TSA showed that the re-
quired information size
(3392) was not reached
when assessing a mini-
mal relevant dif f erence
of 25 meters
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect5
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Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
SF-36 = Short Form-36
PCS = physical component summary measure
MCS = mental component summary measure
1 Training centres could be located in the municipalit ies (outside the hospitals), they were run by physiotherapists hired by
the municipalit ies.
2 Downgraded by 3 levels because of serious lim itat ions in study design (1 level) and very serious risk of imprecision (2
levels).
3 Downgraded by 2 levels because of a very serious lim itat ion in study design (risk of bias due to lack of blinding and
incomplete outcome data).
4 Downgraded by 3 levels because of very serious lim itat ions in study design (2 levels) and serious risk of imprecision (1
level).
5 Downgraded by 1 level because of a serious lim itat ion in study design (1 level).
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B A C K G R O U N D
Description of the condition
Atrial fibrillation (AF) is the most common sustained cardiac ar-
rhythmia (irregular heart beat). It affects 1.5% to 2% of the pop-
ulation in Europe and North America (Ball 2013; Kirchhof 2016;
Nguyen 2013). The incidence of AF is increasing, mainly due
to the ageing population (Ball 2013; Camm 2012; Go 2001;
Ruigomez 2005; Stewart 2001). Atrial fibrillation is associated
with increased mortality, heart failure, stroke, and other throm-
boembolic events (Camm 2010; Kirchhof 2016; Kirchhof 2007;
Stewart 2002). As such, AF has now become a health, social, and
economic burden (Brenyo 2011), and is expected to worsen over
the coming decades (Camm 2012).
Patients with AF can experience palpitations, shortness of breath,
fatigue, dizziness, and syncope (fainting) (Kirchhof 2016). An
American observational study of 655 individuals found that AF
symptoms are a negative predictor for patients’ physical capac-
ity (Atwood 2007). Symptoms and duration of AF episodes vary
within the individual, and from individual to individual (Kirchhof
2016). Five different types of AF exist: first-diagnosed AF, parox-
ysmal AF, persistent AF, long-standing persistent AF, and perma-
nent AF (Kirchhof 2016). First-diagnosed AF is the term given to
the condition when a patient presents with AF for the first time,
regardless of the duration of the arrhythmia, or the presence and
severity of AF-related symptoms. Paroxysmal AF is self-limited,
and usually the rhythm converts spontaneously to sinus rhythm
within 48 hours. In persistent AF, the AF episode lasts longer than
seven days, or requires cardioversion to end the episode. When
the duration of AF exceeds one year, AF is considered to be long-
standing persistent. Finally, permanent AF is when AF is accepted
without further attempts of conversion, or these attempts have
been shown to be unsuccessful or short-lasting (Kirchhof 2016;
Lafuente-Lafuente 2012).
Treatment of AF focuses on re-establishing and maintaining si-
nus rhythm (so-called rhythm control) and protecting the patient
against thromboembolic complications (Kirchhof 2016). When
AF is longer-lasting (as in persistent AF, long-standing persistent
AF, and permanent AF), an additional therapeutic goal is to con-
trol the heart rate in the range of 60 to 80 beats/minute at rest, and
90 to 115 beats/minute when active (rate control). This is achieved
by treatment with antiarrhythmic drugs, which block the func-
tion of the atrioventricular node (Brenyo 2011; Kirchhof 2016).
Treatment should also aim at reducing symptoms and discomfort
related to AF (Brenyo 2011).
Acute management of patients with AF includes acute conversion
to sinus rhythm, protection against thromboembolic events, and
acute improvement of cardiac function. However, AF recurrence is
common despite administration of antiarrhythmic drugs to main-
tain normal sinus rhythm after cardioversion (Kirchhof 2016).
Radiofrequency ablation is sometimes used to treat AF. It is an
invasive treatment developed to cure AF. In a Cochrane systematic
review, Chen and colleagues found that ablation had a better effect
in inhibiting recurrence of AF compared with medical therapies,
but there was limited evidence demonstrating that sinus rhythm
wasmaintained after ablation and after long-term follow-up (Chen
2012). Despite the results of the systematic review, ablation seems
to have an increasingly accepted role in the treatment of AF (
Brenyo 2011; Calkins 2009; Kirchhof 2016).
Studies have found that quality of life is impaired in individu-
als with AF compared to healthy controls, the general popula-
tion, or patients with coronary heart disease in the western world
(Dabrowski 2010; Kang 2004; Thrall 2006). Studies have sug-
gested that maintaining sinus rhythm improves quality of life,
and may be associated with improved survival (Dabrowski 2010;
Dorian 2000; Dorian 2002; Kang 2004; McCabe 2011; Thrall
2006). If patients lack self-management skills, they can experience
distress when trying to handle symptoms of AF, such as palpita-
tions, dyspnoea, and fatigue. Some patients with AF report that
they have not received education or help from health professionals
regarding how to live with AF (McCabe 2011; Lane 2015).
Description of the intervention
Cardiac rehabilitationprovides beneficial effects in patients follow-
ingmyocardial infarction and percutaneous coronary intervention
and in those with heart failure, by improving physical, mental,
cognitive, and social function; and reducing the risk of mortal-
ity, hospitalisation, and healthcare costs (Anderson 2016; Piepoli
2014; Taylor 2014). While there are many definitions of cardiac
rehabilitation, the following presents the combined key elements:
“The coordinated sum of activities required to favourably influ-
ence the underlying cause of cardiovascular disease, as well as to
provide the best possible physical, mental and social conditions, so
that patients may, by their own efforts, preserve or resume optimal
functioning in their community, and through improved health
behaviour, slow or reverse progression of disease” (BACPR 2012).
According to this definition, cardiac rehabilitation is a complex,
comprehensive intervention that should include not only exercise
training, but also education and psychosocial management, and
a behavioural modification programme designed to improve the
physical and emotional well-being of patients with heart disease
(Piepoli 2014). Cardiac rehabilitation can include patient assess-
ments, nutritional counselling, and risk factor management fo-
cusing on lipids, blood pressure, weight, diabetes mellitus, and
smoking cessation (Piepoli 2014).
Studies of exercise training for patients with AF have used various
protocols, indicating the uncertainty of what should be the pre-
cise exercise advice for patients with AF. A review of exercise reha-
bilitation for AF that included 36 studies (six randomised clini-
cal trials) in 1512 patients, made the following recommendations
for exercise training: (1) include three or more weekly sessions of
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moderate intensity whole-body aerobic activities (such as walking,
jogging, cycling, or rowing); (2) each session should be at least 60
minutes long; continue the sessions for at least three months; and
(3) sessions should include stretching, balance exercises, resistance
training, and callisthenics (Giacomantonio 2013). The review in-
cluded studies with a variety of different designs, and did not con-
sider rehabilitation components other than exercise training.
Current recommendations for rehabilitation following myocar-
dial infarction, percutaneous coronary intervention, heart valve
replacement, and heart failure recommend that psychosocial or
educational support, or both, should be offered to patients, in ad-
dition to exercise training (National Board of Health 2013). How-
ever, no such national or international recommendation for reha-
bilitation is currently provided for patients with AF. A systematic
review including 30 studies of mixed designs exploring rehabilita-
tion for patients living with permanent AF, reported that no stud-
ies had included psychosocial support, education, or both, with
the aim of improving the patient’s self-management skills (Lowres
2011).
How the intervention might work
At present, the effect of exercise-based cardiac rehabilitation on
total mortality, serious adverse events, and health-related quality
of life for patients with AF remains uncertain. Existing evidence
from both randomised clinical trials and observational studies in-
dicates that exercise-based interventions positively affect heart rate
control, exercise capacity, symptom burden, improves symptom
and disease management, decrease rates of anxiety and depression,
and increases quality of life for patients with AF (Giacomantonio
2013; Hegbom 2006; Osbak 2011; Reed 2013).
The general cardiovascular mechanisms of physical exercise in the
healthy individual include an increase in heart rate, blood pressure,
whole body oxygen uptake, facilitated by brainstem cardiovascu-
lar activation (Hambrecht 2000). Cardiovascular adaption to dy-
namic physical exercise increases cardiac chamber size, facilitating
an increased stroke volume, lowers blood pressure, lowers resting
heart rate, and improves endurance training, by promoting vol-
ume hypertrophy due to increased wall stretch and increased ve-
nous return (Hawley 2014). Physical exercise also increases activ-
ity in the parasympathetic nervous system, resulting in an increase
in heart rate variability, a blunted arterial baroreflex response, and
an impaired heart rate response to atropine, which independently
decreases the risk of death (Levy 1998). Overall, physical inactivity
is an independent predictor of morbidity and all-cause cardiovas-
cular mortality (Blair 1996; Myers 2002).
Evidence shows that exercise training for cardiac patients, has ben-
efits on the heart and coronary vasculature, including myocardial
oxygen demand, endothelial function, autonomic tone, coagula-
tion and clotting factors, inflammatory markers, and the devel-
opment of coronary collateral vessels (Clausen 1976; Hambrecht
2000). A randomised trial including 30 patients with permanent
AF showed that exercise capacity and heart rate variability im-
proved after two months of exercise training, compared with no
exercise training (Hegbom 2006). A prospective uncontrolled pi-
lot study in 10 patients with AF, found that among older indi-
viduals with AF, exercise training decreased the ventricular rate at
rest and during exercise, and increased exercise capacity follow-
ing regular moderate physical activity (Plisiene 2008). Similarly, a
pre-post study of 20 patients showed increases in physical capac-
ity (a 15% increase measured by maximum oxygen uptake (VO2
max)) after exercise (Mertens 1996). In a randomised clinical trial
including 49 patients with permanent AF, Osbak and colleagues
concluded that exercise capacity measured by VO2 peak improved
significantly after 12 weeks of exercise training compared to no
exercise (Osbak 2011).
We might anticipate the same, or similar effects of exercise-based
cardiac rehabilitation, as seen in other cardiac populations who
typically receive cardiac rehabilitation, i.e., those with myocardial
infarction, post percutaneous intervention, and heart failure. Two
Cochrane reviews have shown that exercise-based cardiac reha-
bilitation has a number of positive effects in these latter popula-
tions that include reductions in deaths and hospitalisation, and
improvements in health-related quality of life (Anderson 2016;
Taylor 2014).
Possible harmful effects of exercise-based cardiac rehabilitation for
patients with AF could include increased risk of adverse events (e.g.
arrhythmias) or serious adverse events like hospitalisation because
of exercise-induced AF. A review reported serious adverse events
to be 2/560 (2 events of Ischaemic chest pain in 560 patients with
AF), and non-serious adverse events to be 43/560 (43 events of
exercise-induced AF), which the authors considered to be a low
risk (Giacomantonio 2013).
We have not been able to find examples of integrated rehabilitation
programmes for patients with AF, or guidelines outlining recom-
mendations for rehabilitation for patients with AF, but Hendriks
and colleagues found, in a randomised trial, that follow-up in a
nurse-led AF clinic significantly reduced cardiovascular hospitali-
sations and mortality compared with usual care (Hendriks 2012;
Hendriks 2014). They also found that the AF-related knowledge
level was higher in the nurse-led group at one year follow-up, com-
pared with the control group that received usual care (Hendriks
2014).
In summary, studies show that exercise training has some positive
effects on patients with AF. However, few studies have included
psycho-educational interventions, which may offer further benefit
to AF patients, such as improvements in mental health. Evidence
exploring mortality and re-hospitalisation is lacking.
Why it is important to do this review
Three reviews have sought to assess the effects of exercise training
for patients with AF (Giacomantonio 2013; Lowres 2011; Reed
2013). In terms of informing rehabilitation practice for AF pa-
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tients, these reviews have a number of limitations: lack of pub-
lished protocol before being conducted (Giacomantonio 2013;
Lowres 2011; Reed 2013); focused solely on exercise training
(Giacomantonio 2013; Reed 2013); included observational stud-
ies (Giacomantonio 2013; Lowres 2011; Reed 2013); and none of
the reviews presented potential harms (Reed 2013). ThisCochrane
review aims to overcome these limitations by assessing the evi-
dence from randomised trials, and investigating both the benefits
and harms of exercise-based rehabilitation in patients with AF.We
will consider not only trials of exercise training alone, but also tri-
als that include a psycho-educational interventional component,
based on our published protocol (Risom 2013).
O B J E C T I V E S
To assess the benefits and harms of exercise-based rehabilitation
programmes compared with no exercise training controls in adults
who currently have AF, or have been treated for AF. We will con-
sider programmes that include exercise training alone or with an-
other intervention (such as a psycho-educational component).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised clinical trials regardless of language, pub-
lication year, publication type, and publication status.
Types of participants
Adult patients (18 years old or older) of both sexes and of all
ethnicities, who currently have AF, or who have been treated for
AF. We included patients regardless of the type of AF, and the
treatment of the arrhythmia.
Types of interventions
Experimental intervention
The rehabilitation programme had to include exercise training.
Exercise-based interventions were defined as: any rehabilitation
programme in an inpatient, outpatient, or community- or home-
based setting that was provided for a patient with AF. The rehabili-
tation programmemust have included an exercise training compo-
nent; it may also have included a psycho-educational component.
The exercise component had to focus on strengthening the pa-
tient’s exercise capacity, and preferably improve their rate control
(i.e. reduced maximum heart rate during exercise). The psycho-
educational component had to focus on psychosocial support or
education, aiming to improve the patient’s self-management skills.
There were no restrictions in the length, intensity, or content of
the training programme.
Control intervention
We included the following control interventions:
• Treatment as usual (e.g. standard medical care, such as
drug, and ablation therapy).
• No intervention.
• Any other type of cardiac rehabilitation programme, as long
as it did not include a physical exercise element.
The last point was added after the protocol was published to in-
clude a comprehensive answer to the objectives in the review.
Co-interventions
We included trials with co-interventions other than rehabilitation
as long as they were equally delivered in the experimental and
control groups. Co-interventions could include: drugs, ablation
techniques, or dietary interventions.
Types of outcome measures
We assessed all outcomes at two time points:
• end of intervention (as defined by the trialists); and
• longest available follow-up.
There was no minimum length of follow-up for the studies that
were eligible for the review.
Primary outcomes
1. Mortality: all-cause mortality and cardiovascular mortality.
2. Serious adverse events: defined as any untoward medical
occurrence that was life threatening, resulting in death, or that
was persistent or leading to significant disability; any medical
event, which had jeopardised the patient or required intervention
to prevent it; any hospital admission, or prolongation of existing
hospital admission (ICH-GCP 2015).
3. Health-related quality of life using generic or disease-
specific validated instruments, e.g. Short Form-36 (SF-36), or
Minnesota Living with Heart Failure questionnaire.
Secondary outcomes
1. Exercise capacity: any measure of exercise capacity,
including direct measurement of oxygen uptake (VO2 peak or
VO2 max), or indirect measures such as exercise time, walking
distance, etc.
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2. Symptoms including palpitations, dyspnoea, dizziness, and
episodes of AF during the intervention period (Kirchhof 2016).
3. Return to work, or loss of employment.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases from their incep-
tion to 14 July 2016, to identify reports of relevant randomised
clinical trials:
1. Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 6) in the Cochrane Library (searched
14 July 2016);
2. The Database of Abstracts of Reviews of Effectiveness
(DARE; 2015, Issue 2) in the Cochrane Library (searched on 14
July 2016);
3. Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, MEDLINE Daily, MEDLINE Ovid (1946 to 14 July
2016);
4. Embase Classic, Embase Ovid (1947 to 2016 week 28);
5. PsycINFO Ovid (1806 to July week 2 2016);
6. Web of Science Core Collection Thomson Reuters (1990 to
14 July 2016);
7. CINAHL EBSCO (1937 to 14 July 2016);
8. LILACS Bireme (1987 to 14 July 2016).
The search strategy for MEDLINE Ovid was adapted for use in
the other databases (Appendix 1). The Cochrane sensitivity-max-
imising randomised clinical trial filter for MEDLINE was applied
and adapted for the other databases where applicable (Lefebvre
2011).
We also conducted a search for adverse effects in the following
databases, from their inception to 14 July 2016.
1. Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, MEDLINE Daily, MEDLINE Ovid (1946 to 14 July
2016);
2. Embase Classic, Embase Ovid (1947 to 2016 week 28).
The search strategies are inAppendix 1. An adverse effects filterwas
applied using terms as recommended in the Cochrane Handbook
of Systematic Reviews of Interventions (Loke 2011).
Searching other resources
We searched the following clinical trial registries on 16 Septem-
ber 2016, to identify ongoing trials. See the search strategy in
Appendix 1:
1. ClinicalTrials.gov (www.clinicaltrials.gov);
2. Controlled-trials.com (www.controlled-trials.com);
3. The World Health Organization (WHO) International
Clinical Trials Registry Platform (ICTRP; apps.who.int/
trialsearch/).
We checked the reference lists of publications for included studies
for any unidentified randomised trials. We did not impose any
language restrictions.
Data collection and analysis
Selection of studies
Two authors (SSR and PPJ) independently read titles and ab-
stracts of all publications identified from searches and excluded
studies that did not meet the inclusion criteria. We retrieved full-
text copies of all potentially relevant studies, and the same two
authors independently assessed them for eligibility, based on the
defined inclusion criteria. The authors resolved disagreements by
discussion, and when necessary, a third author (SKB) was asked
to mediate. The study selection process was documented using a
PRISMA study selection flow chart (Figure 1); excluded studies
with reasons for their exclusion were detailed in theCharacteristics
of excluded studies table.
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Figure 1. Study flow diagram
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Data extraction and management
Two authors (SSR and PPJ) independently extracted data from
the identified trials using standardised data extraction forms. For
the trial conducted by some of the authors in this review, data
were extracted by RST, who was not involved in the trial (Risom
2016). Where data were presented both numerically (in tables or
text) and graphically (in figures), we used numeric data, because of
possible measurement error when estimating from graphs. A third
author (SKB) confirmed all numeric calculations and extractions
from graphs or figures. We resolved any discrepancies by consen-
sus. SSR entered data into Cochrane’s statistical software Review
Manager 5 (RevMan 5 2014). In those cases where there were not
sufficient data or data were unclear in the published trial reports,
we contacted authors, them them to clarify the missing informa-
tion.
We extracted the following data.
1. General information: published or unpublished, title,
authors’ names, source, country, contact address, language of
publication, year of publication, duplicate publication, funding.
2. Study characteristics: design, duration of follow up.
3. Interventions: type and dose of exercise training, other
rehabilitation interventions, setting (i.e. inpatient, outpatient, or
home), time after hospitalisation, and type of control (e.g.
intervention or conventional care).
4. Participants: inclusion and exclusion criteria, number of
participants in intervention and control group, patient
demographics (including sex and ethnicity), clinical
characteristics (including type of AF), and losses to follow-up.
5. Outcomes: mortality (all-cause mortality, cardiovascular
mortality), serious adverse events defined above, health-related
quality of life (using generic or disease-specific validated
instruments), exercise capacity, symptoms (including
palpitations, dyspnoea, dizziness, and attacks during the
intervention period), return to work or loss of employment.
6. Risk of bias: see Assessment of risk of bias in included
studies below.
We sought to compare data from each intervention group of each
parallel group trial; for cross-over trials, we had planned only to
use data from the first phase of the trial (i.e. before cross-over).
Assessment of risk of bias in included studies
Two authors (SSR and PPJ) independently assessed the risk of bias
of the included trials using Cochrane’s tool for assessing risk of
bias (Higgins 2011a). Disagreements were resolved by discussion.
Overall risk of bias
We categorised a trial as being at low risk of bias if the trial was
rated at low risk in all the domains listed below. We categorised a
trial as being at high risk of bias if the risk of bias was rated as either
uncertain or high in any of the domains listed below. We expected
all trials to be categorised at an overall high risk of bias, as it is not
possible to blind participants and personnel (Savovic 2012; Wood
2008). Therefore, we also categorised trials as being at a lower risk
of bias, if a trial was rated low risk of bias in all the domains listed
below except blinding of participants and personnel.
For viewing the bias risk domains see Appendix 2.
Measures of treatment effect
Dichotomous outcomes were expressed as a risk ratio (RR) with
95% confidence intervals (CI). Continuous outcomes were ex-
pressed as a mean difference (MD) between intervention groups.
We preferred not to calculate effect size measures (standardised
mean difference (SMD)), however, when studies used different
instruments to assess the same outcome (e.g. quality of life or ex-
ercise capacity), we calculated and pooled effect sizes using the
SMD and transformed the effect back to the units of one or more
of the specific instruments (Higgins 2011).
Unit of analysis issues
For cluster-randomised trials, we had planned to contact the trial
authors to obtain an estimate of the intra-cluster correlation (ICC)
when appropriate adjustments for the correlation between partic-
ipants within clusters had not been made, or impute it using esti-
mates from the other included trials, or from similar external trials.
We included one trial that used a cross-over design, from which
we only included participants in the analysis before the cross over.
Dealing with missing data
We obtained missing data by contacting the authors of the trials,
if possible. When data remained unavailable, we assessed and dis-
cussed the impact of the missing data.
We analysed dichotomous outcomes according to the intention-
to-treatmethod, which included all participants regardless of com-
pliance or follow-up (Higgins 2011b; Sterne 2011). For the pri-
mary analyses, we assumed that participants lost to follow-up were
alive, had no serious adverse events, and did not experienced loss
of employment. We conducted sensitivity analyses (see below).
For continuous outcomes, we analysed available patient data and
only included data of those for whom results were known (Sterne
2011). Where mean (M) and standard deviations (SD) were miss-
ing, we obtained those directly from the authors. We had also
planned to obtain SDs by calculation, or by imputing SDs from
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other included trials, specifically trials with a low risk of bias, how-
ever, that was not necessary in this review.
Assessment of heterogeneity
We explored clinical heterogeneity by comparing the population,
experimental intervention and control intervention. We observed
statistical heterogeneity in the trials both by visual inspection of a
forest plot and by using a standard Chi² value with a significance
level of P = 0.10. We assessed heterogeneity using the I² statistic.
We interpreted an I² estimate of at least 50% and a statistically
significant Chi² statistic as evidence of a substantial problem with
heterogeneity (Higgins 2011).
Assessment of reporting biases
Small study (publication) bias
We had planned to construct funnel plots for each outcome for
which there were at least ten trials, or all trials were of similar
sizes, to establish the potential influence of small study effects and
potential publication bias (Furukawa 2006). Therefore, due to the
limited number of included studies (six studies), we were not able
to construct funnel plots.
Data synthesis
We performed data synthesis according to recommendations in
the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), and statistical analyses using the latest version
of Review Manager 5 (RevMan 5 2014), and Trial Sequential
Analysis software (TSA 2011). We used both random-effects and
fixed-effect models for meta-analyses (Deeks 2011; DeMets 1987;
DerSimonian 1986). We presented results from the random-ef-
fects model when heterogeneity was high and from fixed-effects
when heterogeneity was low.When differentmeasuring scales were
used (e.g. exercise capacity) to measure the same outcome, we re-
ported data from each measuring scale, and finally calculated a
SMD.
Trial Sequential Analysis
Trial sequential analysis was the planned application to control
risks of random errors, because cumulative meta-analyses are at
risk of producing such errors due to sparse data and repetitive test-
ing on the accumulating data (Thorlund 2009a; Thorlund 2009b;
TSA 2011; Wetterslev 2008; Wetterslev 2009). The underlying
assumption of trial sequential analysis is that testing for signifi-
cancemay be performed each time a new trial is added to themeta-
analysis. To minimise random errors, we calculated the required
information size (i.e. the number of participants needed in a meta-
analysis to detect or reject a certain intervention effect (Wetterslev
2008)). We adjusted the required information size with the diver-
sity (D-square) of the meta-analysis (Wetterslev 2009). We added
the trials according to the year of publication, and if more than
one trial was published in a year, we added trials alphabetically, by
the last name of the first author (Wetterslev 2008).
In our meta-analysis, the diversity-adjusted required information
size for binary outcomeswas based on the assumption of a plausible
relative risk reduction (RRR) of 20% from the proportion with the
outcome in the control group (Wetterslev 2008). For continuous
outcomes, we had planned to assess a minimal relevant difference
of 0.5 SDs, using the SD in the control group. However, instead,
we used aminimal relevant difference of seven points for the SF-36
physical and mental component scales (Berg 2015; Dorian 2000),
3 mL/kg/min for VO2 peak (Mertens 1996), and 25 meters for
the six-minute walking test (ATS statement 2002; Wise 2005;
Gremeaux 2011). These differences were decided before the TSAs
were conducted. As a default, we used a type I error of 5%, a type
II error of 20%, and diversity-adjusted required information size,
unless otherwise stated (Wetterslev 2008; Wetterslev 2009).
We constructed trial sequential monitoring boundaries on the ba-
sis of the required information size and the risks for type I and
type II errors (TSA 2011; Wetterslev 2008). These boundaries de-
termine the statistical inference that may be drawn regarding the
cumulative meta-analysis. If the monitoring boundaries for ben-
efits or harms are crossed before the diversity-adjusted required
information size is reached, it is possible that firm evidence may
be established, and further trials may turn out to be superfluous,
at least for the postulated intervention effect. On the other hand,
if the boundaries are not surpassed, it would most probably be
necessary to continue conducting trials in order to detect or reject
a certain intervention effect.
Subgroup analysis and investigation of heterogeneity
We had planned to perform subgroup analyses on the primary
outcomes using stratifiedmeta-analysis. However, due to the small
number of included trials andparticipants, small number of events,
and poor reporting within the trials, this was not possible.
In the future, we plan to perform subgroup analyses on the fol-
lowing.
• Trials including women compared to trials including men.
• Trials including younger patients compared to trials
including older patients, defined by the trialists or by mean age.
• Trials with exercise intervention only, compared to trials
with exercise intervention plus any other co-intervention, such as
psycho-educational intervention.
• Participants with persistent AF compared to participants
with paroxysmal AF.
• Hospitalisation after rehabilitation because of AF compared
to no hospitalisation because of AF.
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Sensitivity analysis
In the future, for the primary outcomes, we plan to perform sen-
sitivity analyses on the following:
• Trials with overall low risk of bias. If no trials are
categorised as overall low risk of bias, we will analyses trials with
overall lower risk of bias separately.
Dichotomous outcomes
Best-worse case scenario
For this analysis, we assumed that all participants lost to follow-
up in the experimental group had not experienced the outcome
(e.g. death), and all those with missing outcomes in the control
group had experienced the outcome (e.g. death).
Worst-best case scenario
For this analysis, we assumed that all participants lost to follow-
up in the experimental group had experienced the outcome (e.g.
death), and all those with missing outcomes in the control group
had not experienced the outcome (e.g. death).
Continuous data
Assumptions for lost data
It was not necessary to make any assumptions for lost continu-
ous data in this review (see Dealing with missing data). However,
had it been necessary, we would have compared the findings from
our assumptions with data only from those participants who com-
pleted the trials.
Summary of findings
We developed a ’Summary of findings’ table, which incorpo-
rates GRADE methods to assess the quality of the body of ev-
idence supporting each of the major outcomes in our review;
please see Summary of findings for the main comparison (Guyatt
2008). For our assessments, we evaluated the risk of bias, in-
consistency, imprecision, directness, and risk of publication bias.
We used GRADEpro GDT software to create ’Summary of find-
ings’ table (GRADEpro GDT 2014). Our decisions were guided
by the GRADE guidelines (Andrews 2013a; Andrews 2013b;
Balshem 2011; Brunetti 2013; Guyatt 2011a; Guyatt 2011b;
Guyatt 2011c; Guyatt 2011d; Guyatt 2011e; Guyatt 2011f;
Guyatt 2011g; Guyatt 2011h; Guyatt 2013a; Guyatt 2013b;
Guyatt 2013c; Mustafa 2013).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Our electronic searches for this review yielded a total of 4222 ti-
tles (following removal of duplicates). After reviewing titles and
abstracts, we retrieved 19 records for possible inclusion. After ex-
amining the texts, six articles and three ongoing studies were ex-
cluded, and ten records (abstracts and full-text articles) on six ran-
domised clinical trials were included. The study selection process
is summarised in the PRISMA flow diagram shown in Figure 1.
The information on the three ongoing trials can be found in the
Characteristics of ongoing studies table.
Included studies
We included six trials, with a total of 421 patients, described
in ten abstracts and papers, which compared exercise-based re-
habilitation versus no intervention or treatment as usual for pa-
tients with AF or patients who had been treated for AF (Hegbom
2006;Malmo 2016;Osbak 2011; Pippa 2007; Risom 2016; Zeren
2016). Details of included trials are provided in theCharacteristics
of included studies tables.
One trial had a cross-over design, where the patients in the control
group received the intervention after the control period (Hegbom
2006). We have only included the patient data from the first part
of the trial (intervention N = 15; control N = 15).
One trial was conducted in Norway (Hegbom 2006), two in Den-
mark (Osbak 2011; Risom 2016 ), one in Italy (Pippa 2007), one
in Sweden (Malmo 2016), and one in Turkey (Zeren 2016).
All trials reported outcomes at the end of the intervention, which
was either eight weeks (Hegbom 2006), 12 weeks (Osbak 2011;
Zeren 2016), 16 weeks (Pippa 2007), 20 weeks (Malmo 2016),
or six months post-randomisation (Risom 2016).
All six trials compared an exercise training programme with no
additional interventions; one trial included two hours of education
on best practices for cardiovascular risk management for both the
intervention and the control groups (Pippa 2007), and one trial
included psycho-educational consultations as a supplement to the
physical exercise (Risom 2016).
The exercise training interventions differed in duration (8 weeks
to 16 weeks), frequency (from twice a day, seven days a week, to
two or three sessions per week), and session length (15 minutes,
to 90 minutes per session). The exercise training sessions were
supervised or non-supervised home-based sessions. In four of the
trials, the intervention consisted of aerobic training and cool down
and warm-up periods (Hegbom 2006;Malmo 2016; Osbak 2011;
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Risom 2016). The aerobic training was undertaken at an inten-
sity corresponding to 70% of maximal exercise capacity (Osbak
2011), 70% to 90% of maximum heart rate (Hegbom 2006), or
up to 85% to 95% of peak heart rate (Malmo 2016). In one trial,
the Borg scale was used and intensity was progressively increased
during the weeks (Borg 11 to 17 (Risom 2016)), another trial used
85% to 90% of maximal heart rate and Borg 6 to 20 in four-
minute intervals (Malmo 2016).
In the one trial, the intervention consisted of Qi-gong, which is
slow and graceful movements with a focus on breathing, with the
aims of inducing emotional control, increasing muscle tone, and
enhancing body flexibility and strength (Pippa 2007). Another
trial included an intervention that consisted of inspiratory muscle
training at 30% of maximal inspiratory pressure (Zeren 2016).
All six trials recruited adult patients with, or treated for, AF. Three
trials includedpatientswith permanentAF (Hegbom 2006;Osbak
2011; Zeren 2016); in one trial, the patients were diagnosed with
AF at least three months prior to the start of the trial and were
taking anticoagulant treatment for at least two months (Pippa
2007). Another trial recruited patients who had had an ablation for
paroxysmal or persistent AF (Risom 2016), and one trial recruited
patients with nonpermanent AF (Malmo 2016).
Excluded studies
After review of the full-text reports, six publications of six studies
were excluded from the review. One abstract was excluded since
no intervention was applied (Angergard K 2015), and one was
excluded because the control group also received the experimen-
tal intervention (Borland 2015). Two studies were excluded since
patient groups other than patients with AF were included (Kim
2014; Frederix 2015), and two studies were excluded as no ran-
domisation was performed (Mertens 1996; Vanhees 2000). The
three ongoing studies were excluded since no results were pre-
sented (see Ongoing studies).
Risk of bias in included studies
See Figure 2 for overview of risk of bias in the included trials. The
six trials demonstrated various risks of bias across the domains.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Randomisation was adequately reported in four trials. In one trial,
random sequence generation was generated by a random numbers
table (Pippa 2007), one was generated by a random list (Osbak
2011), one was computer-generated (Risom 2016), and one used
prefilled envelops (Zeren 2016). Allocation concealment was se-
cured by computer-generated allocation in three trials, and sealed
envelopes in one trial, as previously described. Two trials did not
describe theirmethodof allocation (Hegbom 2006;Malmo2016).
Blinding
It is not possible to blind patients, clinicians or carers in stud-
ies of exercise-based cardiac rehabilitation. However, outcome as-
sessment should be blinded to patient allocation. Four of the tri-
als stated that they took measures to blind outcome assessment
(Malmo 2016; Osbak 2011; Risom 2016; Zeren 2016).
Incomplete outcome data
We judged all trials to be at low risk for incomplete outcome data.
Information about all patients was available, and the number and
reasons for dropouts and withdrawals were properly described in
all trials. In the trial by Risom and colleagues, a larger number of
patients did not complete all assessments, which is described in
the trial (Risom 2016).
Selective reporting
All outcomes described in the method sections were reported in
all trials. One trial had documented the hierarchy of outcomes in
a published design article (Risom 2013).
Other potential sources of bias
Groups balanced at baseline
In all trials, the intervention groups appeared to be balanced at
baseline.
Groups received same intervention (performance bias)
One trial used a cross-over design, which meant that we only used
the before cross-over data (Hegbom 2006). In the trial by Pippa
and colleagues, both groups received two hours of cardiovascular
disease training, but they did not describe what kind of standard
care the control group received otherwise (Pippa 2007).Osbak and
colleagues described that the patients in the control group were
advised to continue a habitual physical activity, but they did not
describe if the groups received any standard care (Osbak 2011).
Patients in the control groups received standard medical treatment
in two trials (Risom 2016; Zeren 2016), and in one trial, patients
continued their previous exercise habits (Malmo 2016).
For-profit-bias
Three trials described their funding sources as being from inde-
pendent private sources or grants from national government funds
(Malmo 2016; Osbak 2011; Risom 2016). Two trials did not de-
scribe funding sources (Hegbom 2006; Pippa 2007). One trial did
not receive any funding to conduct the trial (Zeren 2016).
Intention-to-treat analysis
Although not stated, three trials appeared to undertake an inten-
tion-to-treat analysis as groups were analysed according to the ini-
tial random allocation (Malmo 2016; Osbak 2011; Pippa 2007);
one trial used intention-to-treat analysis (Risom 2016); and one
trial did not use intention-to-treat in the analysis (Zeren 2016).
The impact of loss to follow-up was not examined in the trials.
Small-trial bias
There were insufficient trials to assess for small trial effects, or to
assess whether the effect estimated varied systematically according
to sample size.
Effects of interventions
See: Summary of findings for the main comparison Exercise
compared to No exercise for adults with atrial fibrillation
Primary outcomes
Mortality (all-cause mortality and cardiovascular mortality)
Two deaths were reported in one of the six trials, one death in each
group (Risom 2016). A trial physician judged both deaths to be
unrelated to the interventionor the trial. Very low-quality evidence
from pooled results showed no clear difference between groups
(RR 1.00, 95% CI 0.06 to 15.78; participants = 421; studies = 6;
I² = 0%; Analysis 1.1).
Trial sequential analysis (TSA) showed that the diversity-adjusted
required information size of 140,645 participants was not reached,
as the accrued number of participants was only 421 (0.3%). We
assumed a control event proportion of 0.5% (as observed in the
control group), and used an empirical continuity correction of
0.01 for zero event trials (Figure 3).
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Figure 3. Mortality. Trial Sequential Analysis on mortality in the six trials was performed based on the
proportion with mortality in the control group set at 0.5%, a relative risk reduction of 20%, a type I error of 5%,
a type II error of 20% (80% power), and diversity of 1%. The diversity-adjusted required information size was
140,645 participants. The blue line represents the cumulative Z-score of the meta-analysis. The green lines
represent the conventional statistical boundaries of P = 0.05. The cumulative Z-curve (blue line) does not cross
the conventional statistical boundaries. The trial sequential monitoring boundaries and the diversity-adjusted
required information size are not shown as the accrued number of participants only amounted to 421/140,645
(0.3%).
Sensitivity analysis
We performed sensitivity analysis to assess the possible impact of
data loss on death. Taking the worst-best case assumption that
all patients lost to follow-up in the exercise group died, and the
patients with missing outcomes in the no-exercise control group
survived, there was no clear difference between groups inmortality
(RR 0.83, 95% CI 0.26 to 2.65; participants = 421; studies = 6; I²
= 0%; Analysis 1.2); we also found no clear difference when taking
the best-worst case assumption (lost to follow-up in exercise group
survived and lost to follow-up in the control group died (RR 0.59,
95% CI 0.08 to 4.35; participants = 421; studies = 6; I² = 0%;
Analysis 1.3)).
Serious adverse events
Only one of the trials stated that they formally collected serious
adverse events as an outcome (Risom 2016). Nevertheless, five tri-
als did report a total of eight serious adverse events; see additional
Table 1 (Hegbom 2006; Malmo 2016; Osbak 2011; Pippa 2007;
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Risom 2016). We found very low-quality of no clear difference
between groups in the number of patients with serious adverse
events (exercise-based rehabilitation: 3/192 (1.56%) versus con-
trol: 5/189 (2.65%); the RR for non-events was 1.01, 95% CI
0.98 to 1.05; participants = 381; studies = 5; I² = 0%; Analysis
1.4).
Trial sequential analysis showed that the diversity-adjusted infor-
mation size of 23,723 participants was not reached. We assumed
a control event proportion of 2.9% (as observed in the control
group), and used an empirical continuity correction of 0.01 for
zero event trials (Figure 4).
Figure 4. Serious adverse events. Trial Sequential Analysis on serious adverse events in four trials was
performed based on the proportion with serious adverse events in the control group set at 2.9%, a relative risk
reduction of 20%, a type I error of 5%, a type II error of 20% (80% power), and diversity of 0%. The diversity-
adjusted required information size was 23,723 participants. The blue line represents the cumulative Z-score of
the meta-analysis. The light blue lines represent the conventional statistical boundaries of P = 0.05. The trial
sequential monitoring boundaries and the diversity-adjusted required information size are not shown as the
accrued number of participants only amounted to 351/23723 (1.48%).
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Sensitivity analysis
We found no clear differences in the risk of serious adverse events
in the sensitivity analyses; worst-best case scenario (assuming all
rehabilitation group drop-outs experienced a serious adverse event,
and all control group drop-outs did not (RR 1.46, 95% CI 0.54
to 3.97; participants = 383; studies = 5; I² = 0%; Analysis 1.5));
and best-worst case scenario (assuming rehabilitation group drop-
outs did not experience a serious adverse event, and all control
drop-outs did (RR 0.65, 95%CI 0.19 to 2.24; participants = 383;
studies = 5; I² = 0%; Analysis 1.6)).
Health-related quality of life (HRQL)
We have provided an overview of the tools used to measure
HRQL in Table 2. Four trials reported HRQL measured by SF-
36 (Hegbom 2006; Malmo 2016; Osbak 2011; Risom 2016).
Hegbom 2006 only reported combined results for the intervention
and control groups, therefore, we were unable to include those
results in the meta-analysis (Hegbom 2006).
SF-36 physical component summary measures (PCS)
Malmo 2016 and Risom 2016) reported results for the mental
(MCS) and physical component summary measures (PCS).When
we pooled results from the PCS, we found low-quality evidence
of no clear difference between groups (MD 1.96, 95% CI -2.50
to 6.42; participants = 224; studies = 2; I² = 69%; Analysis 1.7).
We performed TSA on these two trials (Figure 5). We found that
the cumulative Z-score crossed the diversity-adjusted required in-
formation size, indicating that sufficient information was pro-
vided. Thus, we could conclude that a possible intervention effect,
if any, was less than seven points.
Figure 5. Quality of life, SF-36 physical component score. Trial sequential analysis on quality of life assessed
with SF-36 physical component score assessing a minimal relevant clinical difference of 7 points, and variance
of 70 points (empirical data), was performed based on a type I error of 5%, a type II error of 20% (80% power),
and diversity of 75.78%. The diversity-adjusted required information size was 175 participants. The blue line
represents the cumulative Z-score of the meta-analysis. The green lines represent the conventional statistical
boundaries of P = 0.05. The red inward sloping lines represent the trial sequential monitoring boundaries. The
cumulative Z-curve crossed the diversity-adjusted required information size (red vertical line), indicating that
sufficient information was provided.
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SF-36 mental component summary measures (PCS)
We found low-quality evidence of no clear difference between
groups for the MCS, (MD 1.99, 95% CI -0.48 to 4.46; partic-
ipants = 224; studies = 2; I² = 0%; Analysis 1.8 (Malmo 2016;
Risom 2016)).
We performed TSA on these two trials (Figure 6). We found that
the cumulative Z-score crossed the diversity-adjusted required in-
formation size, indicating that sufficient information was pro-
vided. Thus, we could conclude that a possible intervention effect,
if any, was less than 7 points.
Figure 6. Quality of life, SF-36 mental component score. Trial sequential analysis on quality of life assessed
with SF-36 mental component score assessing a minimal relevant clinical difference of 7 points, and variance of
89 points (empirical data), was performed based on a type I error of 5%, a type II error of 20% (80% power),
and diversity of 0%. The diversity-adjusted required information size was 57 participants. The blue line
represents the cumulative Z-score of the meta-analysis. The green lines represent the conventional statistical
boundaries of P = 0.05. The red inward sloping lines represent the trial sequential monitoring boundaries. The
cumulative Z-curve (blue line) did not cross the trial sequential monitoring boundaries for benefit or harm
(red inward sloping lines). The cumulative Z-curve crossed the diversity-adjusted required information size
(red vertical line) indicating that sufficient information was provided.
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SF-36 subscale summary measures
Three trials reported results for the eight subscales for SF-36 (
Malmo 2016; Osbak 2011; Risom 2016). We found low-quality
evidence frompooled data of the subscales (Analysis 1.12; Analysis
1.13):
• Physical function: MD 1.46, 95% CI -1.26 to 4.18;
participants = 274; studies = 3; I² = 0%;
• Role physical: MD 2.79, 95% CI -0.52 to 6.10;
participants = 274; studies = 3; I² = 0%;
• Bodily pain: MD 0.73, 95% CI -3.99 to 5.45; participants
= 274; studies = 3; I² = 23%;
• General health: MD 7.11, 95% CI 3.46 to 10.77;
participants = 273; studies = 3; I² = 0%;
• Vitality: MD 6.10, 95% CI 1.91 to 10.30; participants =
274; studies = 3;I² = 0%;
• Social functioning: MD 2.85, 95% CI -0.72 to 6.41;
participants = 274; studies = 3; I² = 0%.
• Role emotional: MD 2.91, 95% CI -1.69 to 7.50;
participants = 275; studies = 3; I² = 0%;
• Mental health: MD 2.09, 95% CI -1.08 to 5.26;
participants = 274; studies = 3; I² = 0%;
Minnesota Living with Heart Failure questionnaire (MLHF-
Q)
One study used the MLHF-Q questionnaire to measure self-rated
quality of life, and reported a statistically insignificant difference
between groups in the global score (MLHF-Q total potential) in
favour of the exercise group, measured at post-intervention follow-
up (exercise groupmean 15 points, SD17points versus no exercise
group mean 23 points, SD 21 points, p=0.13) (Osbak 2011). The
trialists did not report if this difference was clinically relevant.
Hospital Anxiety and Depression scale (HADS)
One study also reported a statistical insignificant difference be-
tween groups at follow-up in the HADS-anxiety scale (exercise
group 3.85 points versus no exercise group 3.8 points, p=0.09) and
in the HADS-depression scale (exercise group 2.92 points versus
no exercise group 2.36 points, p=0.41) (Risom 2016).
Exercise capacity
Exercise capacity was assessed by measuring cumulated work (
Hegbom2006), ormaximal power (Watt (Osbak 2011)), obtained
with a cycle ergometer; a six-minute walking test (6MWT (Osbak
2011; Pippa 2007; Risom 2016; Zeren 2016)), or ergospirometry
testing that measured VO2 peak (Malmo 2016; Risom 2016).
VO2 peak
We found moderate-quality evidence from pooled data that ex-
ercise-based rehabilitation increased exercise capacity compared
with no exercise, measured at the end of intervention (MD 3.76,
95% CI 1.37 to 6.15; participants = 208; studies = 2; I² = 0%;
Analysis 1.17).
We performed TSA on exercise capacity, assessed with VO2 peak
with a minimal relevant clinical difference of 3 mL/kg/min, vari-
ance of 78 mL/kg/min (empirical data), based on a type I er-
ror of 5%, a type II error of 20% (80% power), and diversity of
0% (Figure 7). The diversity-adjusted required information size of
271 participants was not met. However, the cumulative Z-curve
crossed the trial sequential monitoring boundaries for benefit, in-
dicating that sufficient information had been obtained, and the
result was not due to random error.
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Figure 7. Exercise capacity, VO2 peak. Trial sequential analysis on exercise capacity assessed with VO2 peak
assessing a minimal relevant clinical difference of 3 mL/kg/min, and variance of 78 mL/kg/min (empirical data),
was performed based on a type I error of 5%, a type II error of 20% (80% power), and diversity of 0%. The
diversity-adjusted required information size was 271 participants. The blue line represents the cumulative Z-
score of the meta-analysis. The green lines represent the conventional statistical boundaries of P = 0.05. The
red inward sloping lines represent the trial sequential monitoring boundaries. The cumulative Z-curve (blue
line) crosses the trial sequential monitoring boundaries for benefit, indicating that sufficient information was
obtained.
Six-minute walking test (6MWT)
We found very low-quality evidence from pooled data that exer-
cise-based rehabilitation increased exercise capacity, measured by
6MWT, compared with no exercise at the end of the intervention
(MD 75.76, 95% CI 14.00 to 137.53; participants = 272; studies
= 4; I² = 85%; Analysis 1.18). The TSA showed that there was not
enough information to confirm or reject a difference of 25 meters
(Figure 8).
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Figure 8. Physical capacity, 6-minute walking test. Trial sequential analysis on exercise capacity assessed
with 6-minute walking test assessing a minimal relevant clinical difference of 25 meters, and variance of 8280
m (empirical data), was performed based on a type I error of 5%, a type II error of 20% (80% power), and
diversity of 87.74%. The diversity-adjusted required information size was 3392 participants. The blue line
represents the cumulative Z-score of the meta-analysis. The green lines represent the conventional statistical
boundaries of P = 0.05. The cumulative Z-curve (blue line) crosses the conventional statistical boundaries.
However, the trial sequential monitoring boundaries and the diversity-adjusted required information size are
not crossed, indicating that insufficient information is obtained.
Cumulated work
One study reports that exercise-based rehabilitation increased ex-
ercise capacity statistically significant compared with no exercise
at post intervention follow-up (exercise group mean 2,077 watts
(SD 753 watts) versus no exercise group mean 1,152 watts (SD
341 watts), p<0.001) (Hegbom 2006).
Maximal power
One study reports that exercise-based rehabilitation increased ex-
ercise capacity statistically significantly compared with no exercise
at post-intervention follow-up (exercise mean 174 watt (SD 56
watt) versus no exercise mean 127 watt (SD 37 watt), p=0.002)
(Osbak 2011).
Standardised mean difference estimate of effect
We combined the results from the three different assessment tools
in a meta-analysis to determine a pooled estimate of effect, and
found very low-quality evidence that exercise-based rehabilitation
increased exercise capacity compared with no exercise at the end
of intervention (SMD 0.86, 95% CI 0.46 to 1.26; participants =
359; studies = 6; I² = 65%; Analysis 1.19).
AF symptoms
Three trials reported AF symptoms (Hegbom 2006;Malmo 2016;
Risom 2016). One study measured AF symptoms at post-inter-
vention follow-up with the Symptom and Severity Checklist ques-
tionnaire (Malmo 2016). They found a larger decrease in the exer-
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cise group compared to the no exercise group in AF frequency (ex-
ercise mean 11.5 points (SD 5.3 points) versus no exercise mean
16.7 points (SD 5.2 points); and AF severity (exercise mean 8.1
points (SD6.1 points) versus no exercisemean 14.1 points (SD3.5
points), however the authors did not report if the difference was
statistically or clinically significant. One study reported post-inter-
vention AF symptoms on the entire population (including cross-
over data), therefore, the data are observational (Hegbom 2006).
It reported no change in AF symptom frequency measured on
the Symptom and Severity Checklist at baseline (mean 14 points
(SD 5 points) and after exercise training (mean 12 points (SD 7
points). No data were reported for the control group. One study
reported self-reported AF symptoms related to physical exercise
(exercise group n = 2, no exercise group n = 1) and not related to
physical exercise (exercise group n = 1, no exercise group n = 2)
(Risom 2016).
Employment loss or return to work
None of the trials reported employment loss or return to work.
Subgroup analyses
There were insufficient trials to undertake subgroup analyses.
Summary of findings tables
We found very low-quality evidence for mortality, serious adverse
events, exercise capacity assessed with 6MWT, and exercise capac-
ity estimated with SMD.We found low-quality evidence for qual-
ity of life assessed with the SF-36 physical and mental component
summary measures, andmoderate-quality evidence for exercise ca-
pacity assessed with VO2 peak (Summary of findings for the main
comparison).
D I S C U S S I O N
Summary of main results
This systematic review identified six randomised clinical trials
with a total of 421 patients that compared exercise-based car-
diac rehabilitation with a no exercise control. The exercise-based
programmes in four trials consisted of both aerobic exercise and
resistance training or joint movements (Hegbom 2006; Malmo
2016; Osbak 2011; Risom 2016); the exercise-based programme
in (Pippa 2007) consisted of Qi-gong (slow and graceful move-
ments that is reported to increase muscle tone and enhance body
flexibility and strength; and in (Zeren 2016), the exercise-based
programme consisted of inspiratory muscle training at 30% of
maximal inspiratory pressure. All six trials compliedwith the Euro-
pean Society of Cardiology recommendation for physical activity
for secondary prevention (Piepoli 2014)). There were inadequate
data to assess the impact of exercise-based cardiac rehabilitation
on the primary outcomes of mortality and serious adverse events.
Regarding health-related quality of life, the trial sequential analysis
showed that there were adequate data to make conclusions for the
SF-36 mental and physical component summary measures, but
the pooled data showed no beneficial effects of exercise training
on these measures. The quality of evidence was low for those out-
comes.
We found moderate to very low-quality of evidence from pooled
estimates that exercise training led to short-term improvements in
exercise capacity, measured at the end of intervention. This effect
could have been due to the high risks of bias and imprecision, as
the trial sequential analysis showed that the required information
size was not reached. Due to lack of data, we could not assess the
impact of exercise-based cardiac rehabilitation on the other sec-
ondary outcomes of this review: symptoms including palpitations,
dyspnoea, dizziness, and AF episodes during the intervention pe-
riod, return to work, or loss of employment (Kirchhof 2016).
Because of the overall low quality of evidence, exercise should still
only be provided in randomised clinical trials and tested against
no intervention. From more trials, we can achieve adequate infor-
mation on patients with AF, so we can assess the risk of important,
patient-relevant, primary outcomes.
Overall completeness and applicability of
evidence
The generalisability of this review is limited by the low number
of randomised clinical trials, the low number of patients with AF
included, and the few patients with outcomes. The included trials
all recruited highly selected study populations. In three of the trials,
the participants had permanent AF (Hegbom 2006; Osbak 2011;
Zeren 2016), in one trial, the patients had to be symptomatic, and
have non-permanent AF to be included (Malmo 2016), another
trial required the patients to have had AF for at least three months
(Pippa 2007), and one trial included patients if they had been
treated with an ablation for paroxysmal or persistent AF (Risom
2016). The patientswere primarily youngermen,whowerewilling
to participate in an exercise training programme.
Only one of the trials included two centres for recruitment (Risom
2016); the other five trials were single-centre trials (Hegbom 2006;
Malmo 2016; Osbak 2011; Pippa 2007; Zeren 2016). Taken to-
gether, these factors potentially limit the applicability of this re-
view to the broader group of AF patients. However, given the po-
tential safety considerations in this population, recruitment to tri-
als of exercise-based rehabilitation is likely to be limited to highly
selected study populations. Larger multi-centre trials of exercise-
rehabilitation with a broader population of patients with AF are
warranted.
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Quality of the evidence
The overall risk of bias summary shows that in some trials, lack of
reporting of methods in the included randomised trials, especially
blinding of patients, personnel, and outcome assessment, made it
difficult to assess their methodological quality and thereby judge
their risk of bias. Other trials described their methodology inmore
depth and therefore, we classified some of the bias domains as low
risk of bias. Using the GRADE methodology and ’Summary of
findings’ table, we assessed the quality of the evidence to range
from moderate to very low across the outcomes. We were able
to judge the minimal clinical important difference for the major
predefined outcomes but not the minor outcomes.
Potential biases in the review process
We conducted the review according to the recommendations pro-
vided in the Cochrane Handbook for Systematic Review of Interven-
tions (Higgins 2011a).
We followed our peer-reviewed and pre-published protocol in or-
der to avoid biases during the conduct and write-up of the review.
In addition, we performed a comprehensive literature search to
identify published and unpublished trials. We contacted study au-
thors for further information.
Our review has some limitations. As already stated, the majority
of included trials were relatively small and were all of short-term
follow-up, therefore, the numbers of reported events were small.
Only one of the trials sought to formally collect data on mortality
and serious adverse events as outcomes. Therefore, inclusions of
these outcomes in this review have been based on our judgments
of the descriptions of losses to follow-up, and data provided by the
authors on request.
Agreements and disagreements with other
studies or reviews
Our findings are broadly in accord with three reviews of exercise-
training for AF (Giacomantonio 2013; Lowres 2011; Reed 2013).
All three reviews included randomised trials plus other studies of
various designs. Some of the same randomised clinical trials that
we included in this systematic review were identified in the reviews
(Hegbom 2006; Osbak 2011; Pippa 2007).
Similar to our findings, mortality was not reported in most re-
views. One review (Lowres 2011) looked for mortality in their
included studies and found that only one trial reported deaths
(Vanhees 2000) - two cardiac-related deaths and one death from
stroke during the intervention period or at least 48 hours after
participating in exercise training. Other Cochrane reviews eval-
uating rehabilitation for patients with heart failure and coronary
heart disease have reported that mortality is the same or lower in
the cardiac rehabilitation group compared with the control group
(Anderson 2014; Anderson 2016; Taylor 2014).
One review (Giacomantonio 2013) found that out of 560 patients
with AF in their systematic review, there were two life-threaten-
ing events reported in the included studies. We find that out of
the six trials we included, five trials reported few serious adverse
events. Cochrane reviews exploring re-hospitalisation among pa-
tients who have participated in cardiac rehabilitation because of
heart failure or coronary heart disease, found a trend towards lower
hospitalisation rates in patients who participated in cardiac reha-
bilitation compared with patients in the control group (Anderson
2016; Taylor 2014). Taken together, it seems likely that it is safe
for patients with AF to participate in exercise-based cardiac reha-
bilitation programmes. However, firm evidence is lacking.
In (Lowres 2011) and (Reed 2013), they reported that health-
related quality of life was measured in few studies in their sys-
tematic reviews. They found that health-related quality of life was
improved on some of the SF-36 domains, and that the physical
component summary was significantly improved (P < 0.05) in
two trials (Lowres 2011). As described in the results, we did not
find a beneficial effect of rehabilitation on health-related quality
of life measured on the SF-36. The SF-36 is designed to measure
general health and physical function rather than disease-specific
symptoms and challenges related to life with AF, and therefore,
it can be discussed how well the SF-36 measures health-related
quality of life among patients with AF or those who have been
treated for AF (Aliot 2014).
Our finding that exercise-based cardiac rehabilitationmay increase
physical capacity in the short term is consistent with the previ-
ous systematic reviews by Lowres and colleagues and Reed and
colleagues (Lowres 2011; Reed 2013). (Lowres 2011) included
randomised trials and prospective cohort studies published in En-
glish, and found a statistically significant increase in physical ca-
pacity in most trials after participating in cardiac rehabilitation.
(Reed 2013) found that exercise capacity improved in all included
trials after exercise intervention. However, neither review followed
a pre-published protocol, they were limited to English literature
only, and included studies of various designs.
Studies have suggested that maintaining sinus rhythm improves
quality of life (Dabrowski 2010;McCabe 2011; Thrall 2006), and
patients can experience distress when trying to handle symptoms
of AF such as palpitations, dyspnoea, and fatigue (McCabe 2011).
Therefore, wewanted to assess these issues in this review.We found
that only two of the included trials assessed symptom severity as
an outcome (Hegbom 2006; Malmo 2016). Hegbom 2006 found
that symptom frequency did not change statistically before and
after a physical exercise intervention. However, they did find a
statistically significant difference in symptom severity. Hegbom
had chosen an incomplete cross-over study design, where patients
served as their own controls. Because of that and the small sample
size, it was not possible to draw a conclusion based on this trial.
Malmo 2016 found that patients in the exercise group experienced
fewer symptoms after the physical exercise program compared to
the patients in the no exercise group.
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Adherence to the rehabilitation programme was discussed in three
of the six included trials. Pippa 2007 described how three partici-
pants did not participate in the full rehabilitation programme due
to lack of interest (two participants), and to retinal embolism (one
participant), but since they all participated in more than half of
the intervention sessions, they were included in the final analy-
sis. Malmo 2016 described six patients who completed less than
80% of the exercise programme due to intercurrent infections and
musculoskeletal symptoms. Risom 2016 also described adherence
to the programme, defined as at least 75% adherence; 44% of
the patients adherend to both the exercise and psycho-educational
programme.There is a need for more focus on adherence in future
rehabilitation research to be able to analyse the effect of the reha-
bilitation programmes in more detail, and to know if lack of effect
is due to low adherence to the programme (Anderson 2014).
As the trials in this review reported few deaths and only few serious
adverse events in the short follow-up, we cannot judge the pos-
sible long-term harms of exercise-based cardiac rehabilitation for
adults with AF. Therefore, future research needs to address long-
term harms of exercise training. In Giacomantonio 2013, they
reported serious adverse events and adverse events among all the
patients with AF in the studies they had included (N = 1120) and
found that two patients experienced a life-threatening event and
43 patients experienced a non-life-threatening event per 13,628
exercise sessions (an estimated total 519,412 minutes of exercise).
In summary, the findings of this review are broadly in ac-
cord with previous systematic reviews of exercise-training for AF
(Giacomantonio 2013; Lowres 2011; Reed 2013). However, all
three reviews included non-randomised studies, which are associ-
ated with increased risk of selection bias, overestimation of ben-
efits, and underestimation of harms (Jakobsen 2013). Reporting
bias cannot be ruled out if studies do not explicitly report having
had a protocol. Also, when including non-randomised studies, we
need to consider how potential confounders are addressed, and
consider the likelihood of increased heterogeneity resulting from
residual confounding and from other biases that vary across stud-
ies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This systematic review shows that there was limited and low-qual-
ity evidence that assessed the impact of exercise-based cardiac re-
habilitation for adults with AF or those who were treated for AF.
There was insufficient evidence to decide if exercise-based rehabil-
itation should be provided for patients with AF. Furthermore, the
trials were conducted primarily in younger males, therefore, these
potential benefits may not be generalisable to the wider commu-
nity of patients with AF or those who were treated for AF. Our
findings were in line with the European Society of Cardiology
guidelines that do not recommend exercise-based cardiac rehabil-
itation for patients with AF because of lack of evidence (Kirchhof
2016). In particular, the impact of exercise-based cardiac rehabil-
itation on mortality and serious adverse events remains unclear,
with low- to very low-quality evidence.
Implications for research
Adequately powered randomised trials, conducted with low risk of
bias are needed to determine whether the effects of exercise-based
cardiac rehabilitation reported in small short-term trials can be
confirmed for outcomes that matter most to patients (i.e. mortal-
ity, serious adverse events, andhealth-related quality of life).Multi-
centre trials that include comprehensive cardiac rehabilitation that
test not only exercise training, but also risk-factor education and
counselling, and psychosocial interventions should be the focus of
future trials of exercise-based rehabilitation inpatientswithAF. Fu-
ture trials should be designed according to the SPIRIT guidelines
and reported according to the CONSORT statements for non-
pharmacological trials (Chan 2013; www.consort-statement.org).
Patients included in exercised-based cardiac rehabilitation studies
are typically highly selected. We still do not know if cardiac reha-
bilitation for patients with AF is safe, due to a small number of
non-serious and serious adverse events reported by the trials iden-
tified in this review. Also, criteria and predictors to identify the pa-
tients who benefit most from rehabilitation are still lacking. Until
more trials providing higher quality evidence exist, exercise-based
cardiac rehabilitation should be tailored and adjusted throughout
as necessary.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Hegbom 2006
Methods RCT cross-over design, Single centre Norway
Participants N = 30 (Intervention N = 15; control N = 15).
Numbers of participants lost to follow up: 2.
Number of early drop outs: 1.
Number with complications:1 (respiratory infection).
Sex: male 87.5%.
Age: Intervention 62 years (SD 7); control: 62 years (SD 7.)
Diagnosis; AF type: Permanent AF.
Ethnicity: Not reported.
Inclusion: Permanent AF, age younger than 75 years, and willing to participate in a 2-
month training program
Exclusion: Patients who already participated in exercise training more than twice weekly,
who had medical contraindications to exercise, or those unable to participate for any
logistic reason
Time after hospitalisation: Not reported.
Interventions Intervention: Duration: 1.25 hr class, 3 sessions/week for 8 weeks. Consisting of 5
minutes of warm-up, three 15-minute periods of aerobics at HRmax, interrupted by
strengthening exercise for the back, thighs, and stomach. The session ended with a 5-
minute cool down followed by 15 minutes of stretching and relaxation. intensity: 70%
to 90% of maximum heart rate. Modality: Not reported. The sessions were supervised
and held at one of two rehabilitation centres
Control:Controls did not perform physical exercise.
Other: Patients were also encouraged to be generally physically active during the training
period
Outcomes Relevant outcomes: QoL by SF-36, exercise testing by cycle ergometer test, measured by
cumulated work that was calculated by adding the workload every minute, symptoms
severity checklist
Other outcomes: 24-hour Holter recording, activities of daily living
Notes follow up 8 weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not described.
Allocation concealment (selection bias) Unclear risk not described.
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Hegbom 2006 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than 10% of the participants were not
analysed.
Selective reporting (reporting bias) Unclear risk We could not identify any protocol pub-
lished before the trial was conducted. All
outcomes described in the method section
of the paper were reported
Groups balanced at baseline Low risk Groupswere balanced at baseline according
to the authors.
Groups received same intervention (perfor-
mance bias)
Unclear risk Both groups received an exercise training
programme, but one group worked as con-
trol group
For-profit-bias Unclear risk Not described.
Intention-to-treat High risk Intention-to-treat not used.
Pippa 2007
Methods RCT; Single centre, Italy; 16-week follow-up
Participants N = 43 (Intervention N = 22; control N = 21).
Numbers of participants lost to follow up: 0.
Number of early drop outs: 3.
Number with complications: 2 (one with retinal embolism and one had deep vein throm-
bosis)
Sex: male Intervention 63.6%; control 76.2%.
Age: Intervention 68.3 years (SD 7.2); control 67.8 years (SD 9.1)
Diagnosis; AF type: Permanent AF defined as at least 3 months with AF
Ethnicity: 100% Caucasian.
Inclusion: diagnosed with AF at least 3 months prior, and were taking anticoagulant
treatment for at least 2 months
Exclusion: ejection fraction < 30%, New York Heart Association class III-IV, or both,
history or suspicion of a recent thromboembolic event, recent heart rate instability, or
other indication for electrocardiographic monitoring during exercise training, chronic
systemic diseases in the acute phase, bone or joint conditions limiting exercise training,
major logistic impairments, involvement in regular training programs, and inability to
give informed consent
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Time after hospitalisation: Not reported.
Interventions Intervention: program consisted of two sessions/week (90 min) for 16 weeks of qigong.
Qigong consist of slow and graceful movements with a focus on breathing. All classes
were assisted by a physician and a therapist. Qigong is reported to induce emotional
control, increase muscle tone, and enhance body flexibility and strength
Control: No intervention.
Other:
All patients: before the start of the study, all participants revised 2 hours of training on
best practices for cardiovascular risk management
Outcomes Relevant outcomes: 6-minute walking test, serious adverse events
Other outcomes: Ejection fraction, Body mass index, biochemical markers
Notes follow-up at 16 weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table.
Allocation concealment (selection bias) Low risk The randomisation was computer-gener-
ated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analyses were carried out on all 43 partic-
ipants.
Selective reporting (reporting bias) Unclear risk We could not identify any protocol pub-
lished before the trial was conducted. All
outcomes described in methods section of
the paper were reported
Groups balanced at baseline Low risk Groups were balanced at baseline, accord-
ing to the authors.
Groups received same intervention (perfor-
mance bias)
Unclear risk Both Intervention and control groups re-
ceived two hours of cardiovascular disease
training, but did not describe what else the
control group received
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For-profit-bias Unclear risk Not described.
Intention-to-treat Low risk The term intention-to-treat (ITT) was not
stated, but it was clear from the paper that
the results were analysed according to ITT
analyses
Osbak 2011
Methods RCT; single centre, Denmark
Participants N = 49, (Intervention N = 25; control N = 24).
Numbers of participants lost to follow up: 0.
Number of early drop outs: 2.
Number with complications: 2 (one had influenza and one needed surgery)
Sex: male 74.5%.
Age: Intervention 69.5 years (SD 7.3); control 70.9 years (SD 8.3)
Diagnosis: AF type: permanent AF.
Ethnicity: not reported.
Inclusion: adults with permanent AF who were willing to participate in a training pro-
gram and able to give informed consent for participation
Exclusion: severe CHF (New York Heart Association classes III-IV), severe refractory
hypertension, previous heart valve surgery, moderate to severe pulmonary disease, low
life expectancy, and lack of ability to exercise
time after hospitalisation: Not reported.
Interventions Intervention: duration: 3 sessions/week; 1-hour classes for 12 weeks; including aerobic
training, cool down andwarm-up periods, at least 30min by Borg 14 to 16 corresponding
to 70% of maximal exercise capacity. The exercise was carried out by ergometer cycling,
walking on stairs, running, fitness training on physioballs, and interval training. The
exercise sessions were carried out in groups of five lead by a physiotherapist
Other: exercise component was based on the ETICA trial. Encouraged to do light exercise
for 30 min daily
Standard care group: They were advised to continue their habitual physical activity
Outcomes Relevant outcomes: Ergometer testing, 6-minute walking test, health-related quality of
life measured by SF-36 and Minnesota Living with Heart Failure questionnaire
Other outcomes: CO measure by cardioScreen, blood samples - natriuretic peptides
(ANP, NT, BNP)
Data on serious adverse events were obtained directly from authors
Notes follow-up 12 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Generated by a random list.
Allocation concealment (selection bias) Low risk Randomisation was carried out by envelopes contain-
ing either the text ’control’ or ’active’. There was no
information about the distribution of the envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Ergometer test: “A physician and a research assistant
blinded to the group allocation status of the patients
were present. However, remarks were sometimes made
by the patient hinting to their trial status. In an exer-
cise study, it is not possible to keep the study double
blinded.Obviously, the patients knewwhich group they
belonged to, but we have tried to maintain blinding as
far as possible for the examiner.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs and all participants were included in the
analysis
Selective reporting (reporting bias) Low risk All outcomes described in methods were reported, but
adverse events and safety were added
Groups balanced at baseline Low risk Judging from the baseline tables, groups were balanced
at baseline
Groups received same intervention (perfor-
mance bias)
Unclear risk Not clear. The control patients were advised to continue
a habitual physical activity. Standard care not described
For-profit-bias Low risk The study was supported by grants from the Danish
Medical Association Research Foundation, Hvidovre
Hospital Research Foundation, and Lundbeck Founda-
tion
Intention-to-treat Low risk The term ’intention-to-treat’ was not stated, but it was
clear from the paper that the results were analysed ac-
cording to ITT
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Risom 2016
Methods RCT; two centres, Denmark.
Participants N = 210, (Intervention N = 105; control N = 105).
Numbers of participants lost to follow up: 3.
Number of early drop-outs: N = 17 (Intervention N = 10; control N = 7)
Number with complications: 2 deaths not related to the trial (Intervention = 2; control
= 1); 1 serious adverse event (Intervention) related to the trial; 23 adverse events (Inter-
vention = 16; control = 7) related to the trial
Sex: male 70% intervention; 73% control.
Age: Intervention 60 years (SD 9); control: 59 years (SD 12.25)
Diagnosis: AF type: paroxysmal or persistent AF.
Ethnicity: not reported.
Inclusion criteria: consecutive patients planned for treatment with radiofrequency
catheter ablation for AF were screened for inclusion. Patients ≥18 years of age, Danish
speaking, and providing oral and written informed consent
Exclusion criteria: unable to understand trial instructions, pregnant or breastfeeding,
reduced ability to follow the planned programme due to other physical illness, prior
to RFA had been engaged in intense physical exercise or sports at a competitive level
several times a week, did not wish to participate, or were enrolled in a clinical trial that
prohibited participation in additional trials.
Time after hospitalisation: patients were approached by the trial nurse for information
about the trial after ablation procedure
Interventions Physical exercise Intervention: duration: 3 sessions/week, 1-hour classes for 12 weeks;
The training program consisted of graduated cardiovascular training based on intensity
prescription using the Borg 15-point scale and strength exercises altered stepwise during
training sessions. Training intensity was progressively increased during the 12 weeks
The program was initiated with one mandatory training session at the hospital; the
continuing physical exercise programwas then offered in three locations according to the
patient’s preference: (1) supervised training at hospital; (2) local trial protocol-certified,
supervised facility; or (3) home-based training with physiotherapist contact when needed
Psycho-educational intervention: duration: 4 consultations/6 months; Education and
information were provided about AF to prepare the patients for expected symptoms,
and a consultation guide was developed to ensure that certain areas were discussed, e.
g. the ablation and fear of AF recurrence. The psycho-educational consultations were
inspired by R.R. Parse’s Human becoming practice methodologies theory. Furthermore,
the consultations complied with recommendations on the use of patient education and
psychosocial support in secondary prevention. Two cardiac care nurses were trained in
the theory and conducted the consultations, a physician could be contacted if needed.
Consultations were performed face-to-face or by telephone
Standard care group: The usual care group followed usual care for patients treated for AF
with RFA, which included a 3- to 6-month follow-up consultation with a physician at
the treating hospital and no further rehabilitation or after-care. Usual care was the same
in both included hospitals
Outcomes Relevant outcomes: mortality, serious adverse events, and adverse events, physical ca-
pacity measured by VO2 testing, health-related quality of life measured by Short Form-
36, and anxiety and depression measured by Hospital Anxiety and Depression scale, 6-
minute walking test, sit-to-stand test
Rawdata on quality of life and 6-minute walking test were obtained directly from authors
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Notes follow-up 6 months.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomised 1:1 to comprehensive cardiac
rehabilitation plus usual care versus usual care alone,
using a computer-generated allocation sequence with a
varying block size of 6, 8, and 12
Allocation concealment (selection bias) Low risk Randomizstion was carried out centrally by a computer,
and was obtained by telephone
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Patients were not blinded to which intervention group
they were in. Outcome assessment staff were blinded to
which group patients were allocated
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Outcome assessment including ergospirometry testing,
data management, and analyses were undertaken by re-
search staff masked to group allocation.”
Incomplete outcome data (attrition bias)
All outcomes
High risk 17 drop-outs (10 intervention, 37 control), were han-
dled by using intention-to-treat analyses
Selective reporting (reporting bias) Low risk A protocol describing the trial was published. All out-
comes described in the methods section were reported
in the results section of the paper. Other outcomes were
described in the protocol and will be reported elsewhere
Groups balanced at baseline Low risk Judging from the baseline table, groups were balanced
at baseline
Groups received same intervention (perfor-
mance bias)
Low risk Patients in the experimental cardiac rehabilitation group
followed a comprehensive programme consisting of ex-
ercise training and psycho-educational consultations
plus usual care. The usual care consisted of a 3- to 6-
month follow-up consultation with a physician at the
treating hospital, and no further rehabilitation or after-
care. Usual care was the same in both included hospitals
For-profit-bias Low risk “This trial was supported by the Danish Strategic
Research Council, The Heart Centre, Rigshospitalet,
Copenhagen, Denmark, Metropolitan University Col-
lege, Copenhagen, Denmark, The Copenhagen Trial
Unit, Denmark and The Lundbeck Foundation, Den-
mark.”
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Intention-to-treat Low risk ITT was used in the analyses.
Malmo 2016
Methods RCT; single centre, Norway.
Participants N = 51, (Intervention N = 26; control N = 25).
Numbers of participants lost to follow up: 0.
Number of early drop outs: 0.
Number with complications: 1 in the control group (1 stroke)
Sex: male 77% intervention; 88% control.
Age: Intervention 56 years (SD 8); control 62 years (SD 9).
Diagnosis; AF type: symptomatic, ECG-documented, non-permanent AF
Ethnicity: not reported.
Inclusion: symptomatic, ECG-documented, non-permanent AF who were referred for
first AF ablation, or to the outpatient clinic
Exclusion: performing endurance training at high intensity > 2 times a week or at mod-
erate intensity for > 3 times a week, previous open heart surgery, left ventricular ejection
fraction < 45%, significant cardiac valve disease, implanted cardiac pacemaker, coronary
artery disease without complete revascularization, or inability to accomplish the exercise
programme
Time after hospitalisation: Patients were recruited when referred for first AF ablation or
to the outpatient clinic
Interventions Intervention: duration: 3 sessions/week for 12 weeks; including aerobic training, warm-
up and cool down periods, with four 4-minute intervals at 85% to 90% of maximal
heart rate and Borg 6 to 20. The exercise was walking or running on a treadmill. The
exercise sessions were carried out in a facility with the option of one additional exercise
session at home when trained in using the heart monitor
Standard care group: continued their previous exercise habits
Outcomes Relevant outcomes: Change in time in AF from baseline to follow-up, AF symptoms,
exercise capacity measured as peak oxygen uptake (VO2 peak), health-related quality
of life measured by SF-36 and AF symptoms and severity checklist, and number of
cardioversions and hospital admissions resulting from AF
Other outcomes: lipid status, cardiac volumes, level of physical activity
Notes follow-up 20 weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not described.
Allocation concealment (selection bias) Unclear risk not described.
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Patients were not blinded to which intervention group
they were in. “The investigators performing the data
analyses were blinded for intervention identity, and none
of the study investigators were involved in treatment of
the patients.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The investigators performing the data analyses were
blinded for intervention identity.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs and all participants were included in the
analysis
Selective reporting (reporting bias) Low risk All outcomes described in methods were reported, ad-
verse events and safety were added
Groups balanced at baseline Low risk Judging from the baseline tables, groups were balanced
at baseline, only differences in patients age were reported
Groups received same intervention (perfor-
mance bias)
High risk The control patients were advised to continue their ha-
bitual physical activity. Standard care not described
For-profit-bias Low risk The study was supported by grants from the Norwe-
gian Council of Cardiovascular Disease (Oslo, Norway)
, Liaison Committee between the Central Norway Re-
gional Health Authority and the Norwegian University
of Science and Technology (Trondheim, Norway), K.G.
Jebsen Foundation, and SINTEF Unimed (Trondheim,
Norway)
Intention-to-treat Low risk All patients completed the intervention and were in-
cluded in the analysis
Zeren 2016
Methods RCT; single centre, Turkey.
Participants N = 38, (Intervention N = 19; control N = 19).
Numbers of participants lost to follow up: 3.
Number of early drop outs: 2.
Number with complications: not reported.
Sex: male 47% intervention, 56% control.
Age: Intervention 66.18 years (SD 8.76); control 67.06 years (SD 6.39)
Diagnosis: AF type: permanent AF.
Ethnicity: not reported.
Inclusion: clinically stable, left ventricular ejection fraction above 40% and New York
Heart AssociationClass I (cardiac disease, but no symptoms and no limitation in ordinary
physical activity, e.g. no shortness of breath when walking, climbing stairs, etc.), and
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Class II (mild symptoms (mild shortness of breath and/or angina) and slight limitation
during ordinary activity)
Exclusion: chronic obstructive lung disease, rheumatic valvular heart disease, previous
heart valve surgery, recent coronary bypass surgery (three months prior to study), acute
myocardial infarction, hypertrophic obstructive cardiomyopathy, and having a pace-
maker
time after hospitalisation: not reported.
Interventions Intervention: duration: 15 minutes twice a day, 7 days a week, for 12 weeks. Once a week
patients in the training group came to the department, had their maximal inspiratory
pressure measured again, and received a supervised inspiratory muscle training session.
Intervention: threshold inspiratory muscle trainer (Threshold IMT) device (Respironics,
U.S.) was used for inspiratory muscle training. The training group received inspiratory
muscle training at 30% of maximal inspiratory pressure. Patients were instructed to
maintain diaphragmatic breathing with the device for five breaths and rest for 5 to 10
seconds before the next five breaths. All patients wore nose-clips during training
Standard medical treatment of permanent atrial fibrillation was based on the ventricular
rate control and antithrombotic therapy, for the purpose of preventing atrial fibrillation-
related complications and thromboembolism
Outcomes Relevant outcomes: functional capacity measured by 6-minute walking test
Other outcomes: pulmonary function, respiratory muscle strength
Notes follow-up 12 weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A numbered series of 38 prefilled envelops specifying
group assignment were used
Allocation concealment (selection bias) Low risk Randomisation was carried out by a computer-based pro-
gram.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Patients were not blinded to which intervention group
theywere in. “Patients’ assessments and inspiratorymuscle
training were performed by different and blinded physio-
therapists.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The physiotherapist that collected the datawas not aware
of which patients belonged to the training group or the
control group. Patients’ assessments and inspiratory mus-
cle training were performed by different physiotherapists.
”
Incomplete outcome data (attrition bias)
All outcomes
High risk 5 drop-outs (2 intervention group, 3 control group); they
were not included in the analysis
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Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported.
Groups balanced at baseline Low risk Judging from the baseline table, groups were balanced at
baseline
Groups received same intervention (perfor-
mance bias)
Low risk “Standard medical treatment of permanent atrial fibril-
lation was based on the ventricular rate control and an-
tithrombotic therapy, for the purpose of preventing atrial
fibrillation-related complications and thromboembolism.
”
For-profit-bias Low risk The researchers were not financially supported to conduct
the trial
Intention-to-treat High risk ITT was not used in the analysis.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Angergard K 2015 No intervention was applied.
Borland 2015 The control group also received the intervention.
Frederix 2015 The study evaluated the cost-effectiveness of a comprehensive cardiac telerehabilitation programme for various
patients with different heart diseases who had participated in cardiac rehabilitation
Kim 2014 The study evaluated the influence of atrial fibrillation on the clinical characteristics and rehabilitation outcomes
of patients with cerebral infarction
Mertens 1996 The study was not randomised
Vanhees 2000 The study was not randomised
Characteristics of ongoing studies [ordered by study ID]
NCT01673139
Trial name or title Effect of 3 years of exercise in patients with atrial fibrillation
Methods RCT
Participants 150 70 to 75 year-old persons with atrial fibrillation included in the “Generation 100 study”
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Interventions 3 years of interval or moderate exercise
Outcomes Primary outcomemeasures: change in burden of atrial fibrillation (timeframe: At baseline and 3 years); burden
of atrial fibrillation measured by Holter monitor and the patient
Secondary outcome measures: size of left ventricle, quality of life, endothelial function, diameter of brachial
artery measured by ultrasound. maximal oxygen uptake, atrial extra systoles, number of hospitalisations with
atrial fibrillation as main diagnosis, total number of electrical cardioversions, number of electrical cardiover-
sions because of atrial fibrillation, size of left atrium, function of left atrium, function of left ventricle,
Starting date September 2012
Contact information Jan Paal Loennechen, Norweigian University of Science and Technology, Trondheim
Notes Norway
NCT01721863
Trial name or title Effects of exercise training in patients with permanent atrial fibrillation
Methods RCT
Participants 58 patients with permanent atrial fibrillation
Interventions Progressive aerobic exercise training with 40% to 85% maximal oxygen consumption for 40 minutes, 3
sessions per week for 12 weeks versus treatment as usual
Outcomes Primary outcome measures: exercise capacity
Secondary outcome measures: heart rate variability, change values of head-up tilt test, endothelial function,
and quality of life
Starting date 2010
Contact information Ying-Tai Wu, National Taiwan University Hospital, Department of Health
Notes Taiwan
NCT01817998
Trial name or title Atrial fibrillation (AF) and physical exercise (EXAF)
Methods RCT
Participants 60 patients older than 18 years with ECG-documented paroxysmal or persistent AF
Interventions Moderate to severe (80% to 85% of maximum capacity) or low intensity (50% of max capacity) training
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Outcomes 1. The effect of physical exercise on AF burden.
2. The effect of physical exercise on the risk of cardiovascular hospitalisation
Starting date November 2012
Contact information Ane Katrine Skielboe: a.k.skielboe@gmail.com
Ulrik Dixen, Consultant: ulrik.dixen@regionh.dk
Notes Denmark
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